Analysis of a 17-amino acid residue, virus-neutralizing microantibody

Journal of General Virology

Volumn 86, Issue 6, 2005, Pages 1791-1800

  Heap, Caroline J ^a,b   Wang, Yuqin ^a   Pinheiro, Teresa J T ^a   Reading, Steven A ^a   Jennings, Keith R ^a   Dimmock, Nigel J ^a  

^a UNIVERSITY OF WARWICK   (United Kingdom)

^b PUBLIC HEALTH ENGLAND   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE; AMINO ACID; GLYCOPROTEIN GP 120; IMMUNOGLOBULIN G; NEUTRALIZING ANTIBODY; VIRUS ANTIGEN;

AMINO ACID ANALYSIS; AMINO ACID SUBSTITUTION; ANTIGEN ANTIBODY REACTION; ANTIGEN BINDING; ARTICLE; BETA SHEET; COMPLEX FORMATION; CONTROLLED STUDY; DATA ANALYSIS; DISSOCIATION; DISSOCIATION CONSTANT; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; MASS SPECTROMETRY; NONHUMAN; PRIORITY JOURNAL; PROTEIN CONFORMATION; SENSITIVITY ANALYSIS; SURFACE PLASMON RESONANCE; VIRUS NEUTRALIZATION;

ALANINE; AMINO ACID SUBSTITUTION; ANTIBODY SPECIFICITY; ANTIGEN-ANTIBODY COMPLEX; COMPLEMENTARITY DETERMINING REGIONS; EPITOPES; HIV ANTIBODIES; HIV ENVELOPE PROTEIN GP120; HIV-1; HUMANS; MASS SPECTROMETRY; NEUTRALIZATION TESTS; OLIGODEOXYRIBONUCLEOTIDES; PEPTIDE FRAGMENTS; SURFACE PLASMON RESONANCE;

HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1; TRIXIS;

EID: 20044396928     PISSN: 00221317     EISSN: None     Source Type: Journal    
DOI: 10.1099/vir.0.80812-0     Document Type: Article

References (59)

1. Barbas, C. F., III, Hu, D., Dunlop, N., Sawyer, L., Cababa, D., Hendry, R. M., Nara, P. L. & Burton, D. R. (1994). In vitro evolution of a neutralizing human antibody to human immunodeficiency virus type 1 to enhance affinity and broaden strain cross-reactivity. Proc Natl Acad Sci U S A 91, 3809-3813.
2. Basmaciogullari, S., Babcock, G. J., van Ryk, D., Wojtowicz, W. & Sodroski, J. (2002). Identification of conserved and variable structures in the human immunodeficiency virus gp120 glycoprotein of importance for CXCR4 binding. J Virol 76, 10791-10800.
3. Bourgeois, C., Bour, J. B., Aho, L. S. & Pothier, P. (1998). Prophylactic administration of a complementarity-determining region derived from a neutralizing monoclonal antibody is effective against respiratory syncytial virus infection in BALB/c mice. J Virol 72, 807-810.
4. Broliden, P.-A., Ljunggren, K., Hinkula, J., Norrby, E., Åkerblom, L. & Wahren, B. (1990). A monoclonal antibody to human immuno-deficiency virus type 1 which mediates cellular cytotoxicity and neutralization. J Virol 64, 936-940.
5. Broliden, P.-A., Makitalo, B., Akerblom, L., Rosen, J., Broliden, K., Utter, G., Jondal, M., Norrby, E. & Wahren, B. (1991). Identification of amino acids in the V3 region of gp120 critical for virus neutralization by human HIV-1-specific antibodies. Immunology 73, 371-376.
6. Cabiaux, V., Brasseur, R., Wattiez, R., Falmagne, P., Ruysschaert, J.-M. & Goormaghtigh, E. (1989). Secondary structure of diphtheria toxin and its fragments interacting with acidic liposomes studied by polarized infrared spectroscopy. J Biol Chem 264, 4928-4938.
7. Calarese, D. A., Scanlan, C. N., Zwick M. B. & 13 other authors (2003). Antibody domain exchange is an immunological solution to carbohydrate cluster recognition. Science 300, 2065-2071.
8. Cao, J., Sullivan, N., Desjardin, E., Parolin, C., Robinson, J., Wyatt R. & Sodroski, J. (1997). Replication and neutralization of human immunodeficiency virus type 1 lacking the V1 and V2 variable loops of the gp120 envelope glycoprotein. J Virol 71, 9808-9812.
9. Casset, F., Roux, F., Mouchet, P. & 10 other authors (2003). A peptide mimetic of an anti-CD4 monoclonal antibody by rational design. Biochem Biophys Res Commun 307, 198-205.
10. Cohen, J. A., Williams, W. V., Weiner, D. B., Geller, H. M. & Greene, M. I. (1990). Ligand binding to the cell surface receptor for reovirus type 3 stimulates galactocerebroside expression by developing oligodendrocytes. Proc Natl Acad Sci U S A 87, 4922-4926.
11. Davies, D. R., Padlan, E. A. & Sheriff, S. (1990). Antibody-antigen complexes. Annu Rev Biochem 59, 439-473.
12. Edinger, A. L., Ahuja, M., Sung, T., Baxter, K. C., Haggarty, B., Doms, R. W. & Hoxie, J. A. (2000). Characterization and epitope mapping of neutralizing monoclonal antibodies produced by immunization with oligomeric simian immunodeficiency virus envelope protein. J Virol 74, 7922-7935.
13. Fontenot, J. D., Zacharopoulos, V. R. & Phillips, D. M. (1996). Proline-rich tandem repeats of antibody complementarity-determining regions bind and neutralize human immunodeficiency virus type 1 particles. J Virol 70, 6557-6562.
14. Fontenot, J. D., Tan, X. & Phillips, D. M. (1998). Structure-based design of peptides that recognise the CD4 binding domain of HIV-1 gp120. AIDS 12, 1413-1418.
15. Goormaghtigh, E., Cabiaux, V. & Ruysschaert, J.-M. (1990). Secondary structure and dosage of soluble and membrane proteins by attenuated total reflection Fourier-transform infrared spectroscopy on hydrated films. Eur J Biochem 193, 409-420.
16. Gorny, M. K., Williams, C., Volsky, B. & 8 other authors (2002). Human monoclonal antibodies specific for conformation-sensitive epitopes of V3 neutralize human immunodeficiency virus type 1 primary isolates from various clades. J Virol 76, 9035-9045.
17. Gorny, M. K., Revesz, K., Williams, C. & 10 other authors (2004). The V3 loop is accessible on the surface of most human immunodeficiency virus type 1 primary isolates and serves as a neutralization epitope. J Virol 78, 2394-2404.
18. Hammache, D., Yahi, N., Piéroni, G., Ariasi, F., Tamalet, C. & Fantini, J. (1998). Sequential interaction of CD4 and HIV-1 gp120 with a reconstituted membrane patch of ganglioside GM3: implications for the role of glycolipids as potential HIV-1 fusion cofactors. Biochem Biophys Res Commun 246, 117-122.
19. Hoffman, T. L. & Doms, R. W. (1999). HIV-1 envelope determinants for cell tropism and chemokine receptor use. Mol Membr Biol 16, 57-65.
20. Hoffman, N. G., Seillier-Moiseiwitsch, F., Ahn, J. H., Walker, J. M. & Swanstrom, R. (2002). Variability in the human immunodeficiency virus type 1 gp120 Env protein linked to phenotype-associated changes in the V3 loop. J Virol 76, 3852-3864.
21. Jackson, N. A. C., Levi, M., Wahren, B. & Dimmock, N. J. (1999). Properties and mechanism of action of a 17 amino acid, V3 loop-specific microantibody that binds to and neutralizes human immunodeficiency virus type 1 virions. J Gen Virol 80, 225-236.
22. Jarrin, A., Andrieux, A., Chapel, A., Buchou, T. & Marguerie, G. (1994). A synthetic peptide with anti-platelet activity derived from a CDR of an anti-GPIIb-IIIa antibody. FEBS Lett 354, 169-172.
23. Javaherian, K., Langlois, A. J., Montefiori, D. C. & 7 other authors (1994). Studies of the conformation-dependent neutralizing epitopes of simian immunodeficiency virus envelope protein. J Virol 68, 2624-2631.
24. Kazlauskaite, J., Sanghera, N., Sylvester, I., Vénien-Bryan, C. & Pinheiro, T. J. T. (2003). Structural changes of the prion protein in lipid membranes leading to aggregation and fibrillization. Biochemistry 42, 3295-3304.
25. Krachnarov, C. P., Kayman, S. C., Honnen, W. J., Trochev, O. & Pinter, A. (2001). V3-specific polyclonal antibodies affinity purified from sera of infected humans effectively neutralize primary isolates of human immunodeficiency virus type 1. AIDS Res Hum Retroviruses 17, 1737-1748.
26. Labrijn, A. F., Poignard, P., Raja, A. & 16 other authors (2003). Access of antibody molecules to the conserved coreceptor binding site on glycoprotein gp120 is sterically restricted on primary human immunodeficiency virus type 1. J Virol 77, 10557-10565.
27. Labrosse, B., Treboute, C., Brelot, A. & Alizon, M. (2001). Cooperation of the V1/V2 and V3 domains of human immunodeficiency virus type 1 gp120 for interaction with the CXCR4 receptor. J Virol 75, 5457-5464.
28. Laune, D., Molina, F., Ferrieres, G. & 7 other authors (1997). Systematic exploration of the antigen binding activity of synthetic peptides isolated from the variable regions of immunoglobulins. J Biol Chem 272, 30937-30944.
29. Levi, M., Sällberg, M., Rudén, U., Herlyn, D., Maruyama, H., Wigzell, H., Marks, J. & Wahren, B. (1993). A complementarity-determining region synthetic peptide acts as a miniantibody and neutralizes human immunodeficiency virus type 1 in vitro. Proc Natl Acad Sci U S A 90, 4374-4378.
30. Levy, J. A. (1998). HIV and the Pathogenesis of AIDS, 2nd edn, pp. 359. Herndon, VA: American Society of Microbiology.
31. Losman, B., Bolmstedt, A., Schønning, K., Björndal, A., Westin, C., Fenyö, E. M. & Olofsson, S. (2001). Protection of neutralization epitopes in the V3 loop of oligomeric human immunodeficiency virus type 1 glycoprotein 120 by N-linked oligosaccharides in the V1 region. AIDS Res Hum Retroviruses 17, 1067-1076.
32. Mbah, H. A., Burda, S., Gorny, M. K., Williams, C., Revesz, K., Zolla-Pazner, S. & Nyambi, P. N. (2001). Effect of soluble CD4 on exposure of epitopes on primary, intact, native human immunodeficiency virus type 1 virions of different genetic clades. J Virol 75, 7785-7788.
33. McLain, L. & Dimmock, N. J. (1994). Single- and multi-hit kinetics of immunoglobulin G neutralization of human immunodeficiency virus type 1 by monoclonal antibodies. J Gen Virol 75, 1457-1460.
34. Millar, A. L., Jackson, N. A. C., Dalton, H., Jennings, K. R., Levi, M., Wahren, B. & Dimmock, N. J. (1998). Rapid analysis of epitope-paratope interactions between HIV-1 and a 17-amino-acid neutralizing microantibody by electrospray ioniszation mass spectrometry. Eur J Biochem 258, 164-169.
35. Minder, D., Böni, J., Schüpbach, J. & Gehring, H. (2002). Immunophilins and HIV-1 infection. Arch Virol 147, 1531-1542.
36. Monnet, C., Laune, D., Laroche-Traineau, J. & 11 other authors (1999). Synthetic peptides derived from the variable regions of an anti-CD4 monoclonal antibody bind to CD4 and inhibit HIV-1 promoter activation in virus-infected cells. J Biol Chem 274, 3789-3796.
37. Moore, J. P., Thali, M., Jameson, B. A. & 12 other authors (1993). Immunochemical analysis of the gp120 surface glycoprotein of human immunodeficiency virus type 1: probing the structure of the C4 and V4 domains and the interaction of the C4 domain and the V3 loop. J Virol 67, 4785-4796.
38. Nehete, P. N., Vela, E. M., Hossain, M. M., Sarkar, A. K., Yahi, N., Fantini, J. & Sastry, K. J. (2002). A post-CD4-binding step involving interaction of the V3 region of viral gp120 with host cell surface glycosphingolipids is common to entry and infection by diverse HIV-1 strains. Antiviral Res 56, 233-251.
39. Parren, P. W. H. I. & Burton, D. R. (2001). The antiviral activity of antibodies in vitro and in vivo. Adv Immunol 77, 195-262.
40. Pinter, A., Honnen, W. J. & Tilley, S. A. (1993). Conformational changes affecting the V3 and CD4-binding domains of human immunodeficiency virus type 1 gp120 associated with Env processing and with binding of ligands to these sites. J Virol 67, 5692-5697.
41. Poignard, P., Saphire, E. O., Parren, P. W. H. I. & Burton, D. R. (2001). gp120: biologic aspects of structural features. Annu Rev Immunol 19, 253-274.
42. Pons, J., Rajpal, A. & Kirsch, J. F. (1999). Energetic analysis of an antigen/antibody interface: alanine scanning mutagenesis and double mutant cycles on the HyHEL10/lysozyme interaction. Protein Sci 8, 958-968.
43. Rizzuto, C., Wyatt, R., Hernandez-Ramoz, N., Sun, Y., Kwong, P. D., Hendrickson, W. A. & Sodroski, J. (1998). A conserved HIV gp120 glycoprotein structure involved in chemokine receptor binding. Science 280, 1949-1953.
44. Saphire, E. O., Parren, P. W. H. I., Pantophlet R. & 7 other authors (2001). Crystal structure of a neutralizing human IgG against HIV-1: a template for vaccine design. Science 293, 1155-1159.
45. Smith, J. W., Hu, D., Satterthwait, A. C., Pinz-Sweeney, S. & Barbas, C. F., III (1994). Building synthetic antibodies as adhesive ligands for integrins. J Biol Chem 269, 32788-32795.
46. Thali, M., Furman, C., Wahren, B., Posner, M., Ho, D. D., Robinson, J. & Sodroski, J. (1992). Cooperativity of neutralizing antibodies directed against the V3 and CD4 binding regions of the human immunodeficiency virus gp120 envelope glycoprotein. J Acquir Immune Defic Syndr 5, 591-599.
47. Welling, G. W., Geurts, T., van Gorkum, J., Damhof, R. A., Drijfhout, J. W., Bloemhoff, W. & Welling-Wester, S. (1990). Synthetic antibody fragment as ligand in immunoaffinity chromatography. J Chromatogr 512, 337-343.
48. Welling, G. W., van Gorkum, J., Damhof, R. A., Drijfhout, J. W., Bloemhoff, W. & Welling-Wester, S. (1991). A ten-residue fragment of an antibody (mini-antibody) directed against lysozyme as ligand in immunoaffinity chromatography. J Chromatogr 548, 235-242.
49. Willey, R. L., Ross, E. K., Buckler-White, A. J., Theodore, T. S. & Martin, M. A. (1989). Functional interaction of constant and variable domains of human immunodeficiency virus type 1 gp120. J Virol 63, 3595-3600.
50. Williams, W. V., Guy, H. R., Rubin, D., Robey, F., Myers, J. N., Kieber-Emmons, T., Weiner, D. B. & Greene, M. I. (1988). Sequences of the cell-attachment sites of reovirus type 3 and its anti-idiotypic/ antireceptor antibody: modeling of their three-dimensional structures. Proc Natl Acad Sci U S A 85, 6488-6492.
51. Williams, W. V., London, S. D., Weiner, D. B., Wadsworth, S., Berzofsky, J. A., Robey, F., Rubin, D. H. & Greene, M. I. (1989a). Immune response to a molecularly defined internal image idiotope. J Immunol 142, 4392-4400.
52. Williams, W. V., Moss, D. A., Kieber-Emmons, T., Cohen, J. A., Myers, J. N., Weiner, D. B. & Greene, M. I. (1989b). Development of biologically active peptides based on antibody structure. Proc Natl Acad Sci U S A 86, 5537-5541.
53. Williams, W. V., Kieber-Emmons, T., VonFeldt, J., Greene, M. I. & Weiner, D. B. (1991a). Design of bioactive peptides based on antibody hypervariable region structures. Development of conformationally constrained and dimeric peptides with enhanced affinity. J Biol Chem 266, 5182-5190.
54. Williams, W. V., Kieber-Emmons, T., Weiner, D. B., Rubin, D. H. & Greene, M. I. (1991b). Contact residues and predicted structure of the reovirus type 3-receptor interaction. J Biol Chem 266, 9241-9250.
55. Winter, G. & Milstein, C. (1991). Man-made antibodies. Nature 349, 293-299.
56. Yang, W.-P., Green, K., Pinz-Sweeney, S., Briones, A. T., Burton, D. R. & Barbas, C. F., III (1995). CDR walking mutagenesis for the affinity maturation of a potent human anti-HIV-1 antibody into the picomolar range. J Mol Biol 254, 392-403.
57. Zhang, P. F., Bouma, P., Park, E. J., Margolick, J. B., Robinson, J. E., Zolla-Pazner, S., Flora, M. N. & Quinnan, G. V., Jr (2002). A variable region 3 (V3) mutation determines a global neutralization phenotype and CD4-independent infectivity of a human immunodeficiency virus type 1 envelope associated with a broadly cross-reactive, primary virus-neutralizing antibody response. J Virol 76, 644-655.
58. Zhang, M.-Y., Shu, Y., Rudolph, D., Prabakaran, P., Labrijn, A. F., Zwick M. B., Lal, R. B. & Dimitrov, D. S. (2004). Improved breadth and potency of an HIV-1-neutralizing human single-chain antibody by random mutagenesis and sequential antigen panning. J Mol Biol 335, 209-219.
59. Zwick, M. B., Parren, P. W. H. I., Saphire, E. O., Church, S., Wang, M., Scott J. K., Dawson, P. E., Wilson, I. A. & Burton, D. R. (2003). Molecular features of the broadly neutralizing immunoglobulin G1 b12 required for recognition of human immunodeficiency virus type 1 gp120. J Virol 77, 5863-5876.